Tag Archives: Shockwave Medical

Canaccord Genuity Believes Shockwave Medical (NASDAQ: SWAV) Still Has Room to Grow

Canaccord Genuity analyst Cecilia Furlong maintained a Buy rating on Shockwave Medical (SWAV – Research Report) today and set a price target of $60.00. The company’s shares closed last Tuesday at $52.25, close to its 52-week high of $53.33. According

Shockwave Medical (SWAV) Receives a Buy from Canaccord Genuity

In a report released today, Cecilia Furlong from Canaccord Genuity maintained a Buy rating on Shockwave Medical (SWAV – Research Report), with a price target of $46.00. The company’s shares closed last Tuesday at $40.79. Currently, the analyst consensus on

Wells Fargo Keeps Their Buy Rating on Shockwave Medical (SWAV)

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Shockwave Medical (SWAV – Research Report) yesterday. The company’s shares closed last Tuesday at $40.79. According to TipRanks.com, Biegelsen is a 5-star analyst with an average return of 11.7% and

Shockwave Medical (SWAV) Gets a Hold Rating from Oppenheimer

Oppenheimer analyst Suraj Kalia maintained a Hold rating on Shockwave Medical (SWAV – Research Report) yesterday. The company’s shares closed last Monday at $47.74. According to TipRanks.com, Kalia is a 4-star analyst with an average return of 5.8% and a

Shockwave Medical (SWAV) Receives a Hold from Morgan Stanley

Morgan Stanley analyst David Lewis maintained a Hold rating on Shockwave Medical (SWAV – Research Report) today and set a price target of $47.00. The company’s shares closed last Monday at $44.90. According to TipRanks.com, Lewis is a 5-star analyst